Stay updated on HD IL-2 + Anti-PD-1 for Anti-PD-1 Resistant MM & RCC Clinical Trial
Sign up to get notified when there's something new on the HD IL-2 + Anti-PD-1 for Anti-PD-1 Resistant MM & RCC Clinical Trial page.

Latest updates to the HD IL-2 + Anti-PD-1 for Anti-PD-1 Resistant MM & RCC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA general NIH announcement about changing terminology appears above the page, which still displays a 403 Forbidden error instead of the study record. The site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe site footer revision advances from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check39 days agoChange DetectedThe study page now shows a 403 Forbidden error, replacing the expected study details with an error screen. This indicates an access or server issue that prevents viewing the ClinicalTrials.gov record for this study.SummaryDifference19%

- Check60 days agoChange DetectedRevision tag updated to v3.6.6, replacing v3.6.5. This reflects a minor page update and does not affect study data or eligibility.SummaryDifference0.1%

- Check82 days agoChange DetectedThe study record now includes posted results for the HD IL-2 and anti-PD-1 trial, with RECIST-based outcomes (ORR, PFS) and dates/investigator details. The previous title and older endpoint descriptions were removed as part of this update.SummaryDifference2%

- Check103 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, signaling a minor system or UI update without changes to the study information.SummaryDifference0.1%

Stay in the know with updates to HD IL-2 + Anti-PD-1 for Anti-PD-1 Resistant MM & RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HD IL-2 + Anti-PD-1 for Anti-PD-1 Resistant MM & RCC Clinical Trial page.